Predicted to die within months from prostate cancer, Abdelbaset Ali Mohmed al-Megrahi, the Lockerbie bomber responsible for the deaths of 270 people when Pan Am flight 103 exploded in mid-air over Lockerbie Scotland in 1988, is still very much alive.

Dennis Hopper has been diagnosed with prostate cancer and was forced to cancel his appearance at an exhibition of his artwork and photography in Australia so he could seek treatment. Dennis Hopper, 73, is best know for his roles in "Rebel Without a Cause," "Hoosiers," "Apocalypse Now" and "Easy Rider".

For years, the American Cancer Society has promoted screening as an effective means of catching and killing tumors before they spread. Research published this week in the Journal of the American Medical Association suggests that screening for some cancers may be less effective than previously thought, and that in turn is leading the ACS to reconsider its advice.

New research reveals the prostate specific antigen (PSA) test may lead to overdiagnosis and overtreatment of prostate cancer.

Prostate cancer patients of low socioeconomic status are more likely to die than patients with higher incomes. That is the finding of a new study from Swiss researchers to be published in the December 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study's findings indicate that poor prostate cancer patients receive worse care than their wealthier counterparts.

For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.

Immune therapies have been explored as a way to treat cancer after it develops. But a new study from the University of Michigan Comprehensive Cancer Center suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.

In the largest study of its kind, the international team of pathologists studied an initial 4,000 prostate cancer patients over a period of 15 years to further understanding into the natural progression of the disease and how it should be managed. The research, published in the British Journal of Cancer, could be used to develop a blood test to distinguish between aggressive and non-aggressive forms of prostate cancer.

Over 1 million additional men were likely to have been incorrectly diagnosed and treated for prostate cancer.

A team of scientists led by researcher Brenda Hernandez, Ph.D., M.P.H.—an assistant professor at the University of Hawai'i at Mānoa's Cancer Research Center of Hawai'i—has reported that body mass in younger and older adulthood, and weight gain between these life periods, may influence a man's risk for prostate cancer.

Each year over 190,000 men in the US are diagnosed with prostate cancer. Many others go undiagnosed. That is one reason why September is Prostate Cancer Awareness month.

A new study just released by the researchers from the University of Utah and Columbia University shows there is a link to the virus XMRV to prostate cancer. The study results were published in the Proceedings of the National Academy of Sciences showed that 27% of the human prostate cancer tumors in the study had XMRV.